Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study

Figure 3

Schematic representation of some oncogenic mechanisms of calcineurin inhibitors (CNI), azathioprine, and thymoglobulin.